Phosphoinositide 3-kinases as a common platform for multi-hormone signaling

Journal of Endocrinology

Volumn 194, Issue 2, 2007, Pages 243-256

  Hirsch, Emilio ^a   Costa, Carlotta ^a   Ciraolo, Elisa ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CALCIUM CHANNEL; ENDOTHELIN 1; ESTROGEN RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER 4; GUANOSINE TRIPHOSPHATASE; INSULIN; INSULIN RECEPTOR; LEPTIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

BREAST CANCER; CARDIOVASCULAR DISEASE; CELL GROWTH; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CELL PHYSIOLOGY; ENZYME ACTIVATION; HUMANS; INSULIN; LIPID METABOLISM; SECOND MESSENGER SYSTEMS;

EID: 34547895443     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-07-0097     Document Type: Review

References (123)

1. Abe H, Yamada N, Kamata K, Kuwaki T, Shimada M, Osuga J, Shionoiri F, Yahagi N, Kadowaki T, Tamemoto H et al. 1998 Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. Journal of Clinical Investigation 101 1784-1788.
2. Agati JM, Yeagley D & Quinn PG 1998 Assessment of the roles of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, and protein kinase C in insulin inhibition of cAMP-induced phosphoenolpyruvate carboxykinase gene transcription. Journal of Biological Chemistry 273 18751-18759.
3. Antonetti DA, Algenstaedt P & Kahn CR 1996 Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Molecular and Cellular Biology 16 2195-2203.
4. Araki E, Sun XJ, Haag BL III, Chuang LM, Zhang Y, Yang-Feng TL, White MF & Kahn CR 1993 Human skeletal muscle insulin receptor substrate-1. Characterization of the cDNA, gene, and chromosomal localization. Diabetes 42 1041-1054.
5. Araki E, Lipes MA, Patti NM, Bruning JC, Haag B III, Johnson RS & Kahn CR 1994 Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372 186-190.
6. Bandyopadhyay G, Standaert ML, Zhao L, Yu B, Avignon A, Galloway L, Karnam P, MoscatJ & Farese RV 1997 Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport. Journal of Biological Chemistry 272 2551-2558.
7. Bandyopadhyay GK, Yu JG, Ofrecio J & Olefsky JM 2005 Increased p85/ 55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54 2351-2359.
8. Barthel A, Schmoll D & Unterman TG 2005 FoxO proteins in insulin action and metabolism. Trends in Endocrinology and Metabolism 16 183-189.
9. Berridge MJ 2005 Unlocking the secrets of cell signaling. Annual Review of Physiology 67 1-21.
10. Bjornholm M, Kawano Y, Lehtihet M & Zierath JR 1997 Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46 524-527.
11. Brachmann SM, Ueki K, Engelman JA, Kahn RC & Cantley LC 2005 Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Molecular and Cellular Biology 25 1596-1607.
12. Brock C, Schaefer M, Reusch HP, Czupalla C, Michalke M, Spicher K, Schultz G & Nurnberg B 2003 Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma. Journal of Cell Biology 160 89-99.
13. Bruno A, Conus S, Schmid I & Simon HU 2005 Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. Journal of Immunology 174 8090-8096.
14. Cai D, Dhe-Paganon S, Melendez PA, Lee J & Shoelson SE 2003 Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. Journal of Biological Chemistry 278 25323-25330.
15. Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Francon B et al. 2005 Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nature Medicine 11 936-943.
16. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV & Auricchio F 2001 PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO Journal 20 6050-6059.
17. Chaussade C, Pirola L, Bonnafous S, Blondeau F, Brenz-Verca S, Tronchere H, Portis F, Rusconi S, Payrastre B, Laporte J et al. 2003 Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate (PtdIns(3)P) phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Molecular Endocrinology 17 2448-2460.
18. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K et al. 2001 Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes and Development 15 2203-2208.
19. Chen D, Mauvais-Jarvis F, Bluher M, Fisher SJ, Jozsi A, Goodyear LJ, Ueki K & Kahn CR 2004 p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Molecular and Cellular Biology 24 320-329.
20. Cho H, Thorvaldsen JL, Chu Q, Feng F & Birnbaum MJ 2001a Akt1/ PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. Journal of Biological Chemistry 276 38349-38352.
21. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB III, Kaestner KH, Bartolomei MS, Shulman GI & Birnbaum MJ 2001b Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292 1728-1731.
22. Cross DA, Alessi DR, Cohen P, Andjelkovich M & Hemmings BA 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 785-789.
23. Cully M, You H, Levine AJ & Mak TW 2006 Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Reviews. Cancer 6 184-192.
24. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R & Zeiher AM 1999 Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 601-605.
25. Di Paolo G & De Camilli P 2006 Phosphoinositides in cell regulation and membrane dynamics. Nature 443 651-657.
26. Dugourd C, Gervais M, Corvol P & Monnot C 2003 Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation. Hypertension 41 882-890.
27. Engelman JA, Lou J & Cantley LC 2006 The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nature Reviews. Genetics 7 606-619.
28. Folli F, Saad MJ, Backer JM & Kahn CR 1993 Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. Journal of Clinical Investigation 92 1787-1794.
29. Foukas LC, Claret M, Pearce W, Okkenhaug K, Meek S, Peskett E, Sancho S, Smith AJ, Withers DJ & Vanhaesebroeck B 2006 Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441 366-370.
30. Fruman DA, Mauvais-Jarvis F, Pollard DA, Yballe CM, Brazil D, Bronson RT, Kahn CR & Cantley LC 2000 Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nature Genetics 26 379-382.
31. Fu Z, Aronoff-Spencer E, Backer JM & Gerfen GJ 2003 The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling. PNAS 100 3275-3280.
32. Garcia Z, Silio V, Marques M, Cortes I, Kumar A, Hernandez C, Checa AI, Serrano A & Carrera AC 2006 A PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis. EMBO Journal 25 4740-4751.
33. George S, Rochford JJ, Wolfrum. C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL et al. 2004 A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304 1325-1328.
34. Gonzalez-Rodriguez A, Clampit JE, Escribano O, Benito M, Rondinone CM & Valverde AM 2007 Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes. Endocrinology 148 594-608.
35. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ & Dohm, GL 1995 Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. Journal of Clinical Investigation 95 2195-2204.
36. Gout I, Dhand R, Panayotou G, Fry MJ, Hiles I, Otsu M & Waterfield MD 1992 Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system. Biochemical Journal 288 395-405.
37. Greer EL & Brunet A 2005 FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24 7410-7425.
38. Greger JG, Fursov N, Cooch N, McLarney S, Freedman LP, Edwards DP & Cheskis BJ 2007 Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase. Molecular and Cellular Biology 27 1904-1913.
39. Guo X, Razandi M, Pedram A, Kassab G & Levin ER 2005 Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. Journal of Biological Chemistry 280 19704-19710.
40. Harvey J, McKay NG, Walker KS, Van der Kaay J, Downes CP & Ashford ML 2000 Essential role of phosphoinositide 3-kinase in leptin-induced K(ATP) channel activation in the rat CRI-G1 insulinoma cell line. Journal of Biological Chemistry 275 4660-4669.
41. Hawkins PT, Anderson KE, Davidson K & Stephens LR 2006 Signalling through Class I PI3Ks in mammalian cells. Biochemical Society Transactions 34 647-662.
42. Hayashi K, Shibata K, Morita T, Iwasaki K, Watanabe M & Sobue K 2004 Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. Journal of Biological Chemistry 279 40807-40818.
43. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC & Bender JR 2000 Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circulation Research 87 677-682.
44. Hinchliffe K & Irvine R 1997 Inositol lipid pathways turn turtle. Nature 390 123-124.
45. Hirsch E, Lembo G, Montrucchio G, Rommel C, Costa C & Barberis L 2006 Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. Thrombosis and Haemostasis 95 29-35.
46. Inoue G, Cheatham B, Emkey R & Kahn CR 1998 Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. Journal of Biological Chemistry 273 11548-11555.
47. Inukai K, Anai M, Van Breda E, Hosaka T, Katagiri H, Funaki M, Fukushima Y, Ogihara T, Yazaki Y, Kikuchi M et al. 1996 A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK is generated by alternative splicing of the p85alpha gene. Journal of Biological Chemistry 271 5317-5320.
48. Kalesnikoff J, Sly LM, Hughes MR, Buchse T, Rauh MJ, Cao LP, Lam V, Mui A, Huber M & Krystal G 2003 The role of SHIP in cytokine-induced signaling. Reviews of Physiology, Biochemistry and Pharmacology 149 87-103.
49. Katome T, Obata T, Matsushima R, Masuyama N, Cantley LC, Gotoh Y, Kishi K, Shiota H & Ebina Y 2003 Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/ protein kinase B isoforms in insulin actions. Journal of Biological Chemistry 278 28312-28323.
50. Kellerer M, Koch M, Metzinger E, Mushack J, Capp E & Haring HU 1997 Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40 1358-1362.
51. Kerouz NJ, Horsch D, Pons S & Kahn CR 1997 Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. Journal of Clinical Investigation 100 3164-3172.
52. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B et al. 2006 A pharmacological map of the PI3-K family defines a role for pl 10alpha in insulin signaling. Cell 125 733-747.
53. Kotani K, Ogawa W, Hino Y, Kitamura T, Ueno H, Sano W, Sutherland C, Granner DK & Kasuga M 1999 Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Clambda do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription. Journal of Biological Chemistry 274 21305-21312.
54. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H et al. 2000 Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49 1880-1889.
55. Kurlawalla-Martinez C, Stiles B, Wang Y, Devaskar SU, Kahn BB & Wu H 2005 Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Molecular and Cellular Biology 25 2498-2510.
56. Kutateladze TG 2006 Phospharidylinositol 3-phosphate recognition and membrane docking by the FYVE domain. Biochimica et Biophysica Acta 1761 868-877.
57. 2+ channels by phosphatidylinositol 3,4,5-trisphosphate. Circulation Research 95 300-307.
58. Lemmon MA 2007 Pleckstrin homology (PH) domains and phosphoinositides. Biochemical Society Symposium 74 81-93.
59. Lemmon MA, Ferguson KM, O'Brien R, Sigler PB & Schlessinger J 1995 Specific and high-affinity binding of inosital phosphates to an isolated pleckstrin homology domain. PNAS 92 10472-10476.
60. Liang J & Slingerland JM 2003 Multiple roles of the P13K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2 339-345.
61. Lindmo K & Stenmark H 2006 Regulation of membrane traffic by phosphoinositide 3-kinases. Journal of Cell Science 119 605-614.
62. Lindvall J & Islam TC 2002 Interaction of Btk and Akt in B cell signaling. Biochemical and Biophysical Research Communications 293 1319-1326.
63. Macrez N, Mironneau C, Carricaburu V, Quignard JF, Babich A, Czupalla C, Nurnberg B & Mironneau J 2001 Phosphoinositide 3-kinase isoforms selectively couple receptors to vascular L-type Ca(2 +) channels. Circulation Research 89 692-699.
64. Maffucci T & Falasca M 2007 Phosphoinositide 3-kinase-dependent regulation of phospholipase Cgamma. Biochemical Society Transactions 35 229-230.
65. Maffucci T, Brancaccio A, Piccolo E, Stein RC & Falasca M 2003 Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO Journal 22 4178-4189.
66. Mansour E, Pereira FG, Araujo EP, Amaral ME, Morari J, Ferraroni NR, Ferreira DS, Lorand-Metze I & Velloso LA 2006 Leptin inhibits apoptosis in thymus through a janus kinase-2-independent, insulin receptor substrate-1/phosphatidylinositol-3 kinase-dependent pathway. Endocrinology 147 5470-5479.
67. Michell RH 2007 Evolution ofthe diverse biological roles of inositols. Biochemical Society Symposium 74 223-246.
68. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E & Auricchio F 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO Journal 15 1292-1300.
69. Munzberg H & Myers MG Jr 2005 Molecular and anatomical determinants of central leptin resistance. Nature Neuroscience 8 566-570.
70. Murga C, Fukuhara S & Gutkind JS 2000 A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt. Journal of Biological Chemistry 275 12069-12073.
71. Naga Prasad SV, Esposito G, Mao L, Koch WJ & Rockman HA 2000 Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy Journal of Biological Chemistry 275 4693-4698.
72. Nakae J, Kitamura T, Ogawa W, Kasuga M & Accili D 2001 Insulin regulation of gene expression through the forkhead transcription factor Foxo1 (Fkhr) requires kinases distinct from Akt. Biochemistry 40 11768-11776.
73. Pacold ME, Suite S, Perisic O, Lara-Gonzalez S, Davis CT, Walker EH, Hawkins PT, Stephens L, Eccleston JF & Williams RL 2000 Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103 931-943.
74. Patrucco E, Notte A, Barberis L, Selvetella G, Maffei A, Brancaccio M, Marengo S, Russo G, Azzolino O, Rybatkin SD et al. 2004 PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118 375-387.
75. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C et al. 2004 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phosphoinositide-3 kinase/Akt signaling. Circulation Research 95 692-699.
76. Pedram A, Razandi M, Aitkenhead M & Levin ER 2005 Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. Journal of Biological Chemistry 280 26339-26348.
77. Plum L, Schubert M & Brunning JC 2005 The role of insulin receptor signaling in the brain. Trends in Endocrinology and Metabolism 16 59-65.
78. Pons S, Asano T, Glasheen E, Miralpeix M, Zhang Y, Fisher TL, Myers MG Jr, Sun XJ & White MF 1995 The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Molecular and Cellular Biology 15 4453-4465.
79. Quignard JF, Mironneau J, Carricaburu V, Fournier B, Babich A, Nurnberg B, Mironneau C & Macrez N 2001 Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes. Journal of Biological Chemistry 276 32545-32551.
80. Ramm G, Larance M, Guilhaus M & James DE 2006 A role for 14-3-3 in insulin-stimulated GLUT4 translocation through its interaction with the RabGAP AS160. Journal of Biological Chemistry 281 29174-29180.
81. Ren SY, Bolton E, Mohi MG, Morrione A, Neel BG & Skorski T 2005 Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences. Molecular and Cellular Biology 25 8001-8008.
82. Rodriguez A, Forruno A, Gomez-Ambrosi J, Zalba G, Diez J & Fruhbeck G 2007 The inhibitory effect of leprin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 148 324-331.
83. Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH & Smith U 1997 Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. PNAS 94 4171-4175.
84. Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, Yu JS, Malmstrom PO, Mansukhani M, Enoksson J et al. 2005 PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Research 65 2554-2559.
85. Sabatini DM, 2006 mTOR and cancer: insights into a complex relationship. Nature Reviews. Cancer 6 729-734.
86. Saward L & Zahradka P 1997 Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circulation Research 81 249-257.
87. Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM & Medema RH 2002 Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Molecular and Cellular Biology 22 7842-7852.
88. Schreyer S, Ledwig D, Rakatzi I, Kloting I & Eckel J 2003 Insulin receptor substrate-4 is expressed in muscle tissue without acting as a substrate for the insulin receptor. Endocrinology 144 1211-1218.
89. Sciacchitano S & Taylor SI 1997 Cloning, tissue expression, and chromosomal localization of the mouse IRS-3 gene. Endocrinology 138 4931-4940.
90. Shepherd PR 2005 Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiologica Scandinavica 183 3-12.
91. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW & Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 538-541.
92. Sonenberg N & Pause A 2006 Signal transduction. Protein synthesis and oncogenesis meet again. Science 314 428-429.
93. Stephens LR, Eguinoa A, Erdjument-Bromage H, Lui M, Cooke F, Coadwell J, Smrcka AS, Thelen M, Cadwallader K, Tempst P et al. 1997 The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89 105-114.
94. Stoica GE, Franke TF, Wellstein A, Czubayko F, List HJ, Reiter R, Morgan E, Martin MB & Stoica A 2003 Estradiol rapidly activates Akt via the ErbB2 signaling pathway. Molecular Endocrinology 17 818-830.
95. Suire S, Hawkins P & Stephens L 2002 Activation of phosphomositide 3-kinase gamma by Ras. Current Biology 12 1068-1075.
96. Suire S, Coadwell J, Ferguson GJ, Davidson K, Hawkins P & Stephens L 2005 p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide, 3-kinase p110gamma. Current Biology 15 566-570.
97. Suire S, Condliffe AM, Ferguson GJ, Ellson CD, Guillou H, Davidson K, Welch H, Coadwell J, Turner M, Chilvers ER et al. 2006 Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils. Nature Cell Biology 8 1303-1309.
98. Sun XJ, Pons S, Wang LM, Zhang Y, Yenush L, Burks D, Myers MG Jr, Glasheen E, Copeland NG, Jenkins NA et al. 1997 The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Molecular Endocrinology 11 251-262.
99. Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV & Cheng JQ 2001 Phosphatidylinositol-3-OH Kinase (PI3K)/ AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ER alpha) via interaction between ER alpha and PI3K. Cancer Research 61 5985-5991.
100. Szanto I & Kahn CR 2000 Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. PNAS 97 2355-2360.
101. Takahashi T, Taniguchi T, Konishi H, Kikkawa U, Ishikawa Y & Yokoyama M 1999 Activation of Akt/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells. American Journal of Physiology 276 H1927-H1934.
102. Taniguchi CM, Tran TT, Kondo T, Luo J, Ueki K, Cantley LC & Kahn CR 2006 Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. PNAS 103 12093-12097.
103. Terauchi Y, Tsuji Y, Satoh S, Minoura H, Murakami K, Okuno A, Inukai K, Asano T, Kaburagi Y, Ueki K et al. 1999 Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphomositide 3-kinase. Nature Genetics 21 230-235.
104. Thong FS, Dugani CB & Klip A 2005 Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology 20 271-284.
105. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C & Pandolfi PP 2006 Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441 523-527.
106. Tschopp O, Yang ZZ, Brodbeck D, Dummler BA, Hemmings-Mieszczak M, Watanabe T, Michaelis T, Frahm J & Hemmings BA 2005 Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 132 2943-2954.
107. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC & Kahn CR 2002a Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Molecular and Cellular Biology 22 965-977.
108. Ueki K, Yballe CM, Brachmann SM, Vicent D, Watt JM, Kahn CR & Cantley LC 2002b Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase. PNAS 99 419-424.
109. Ueki K, Fruman DA, Yballe CM, Fasshauer M, Klein J, Asano T, Cantley LC & Kahn CR 2003 Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. Journal of Biological Chemistry 278 48453-48466.
110. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J et al. 2004 Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 200-205.
111. Vanhaesebroeck B & Alessi DR 2000 The PI3K-PDK1 connection: more than just a road to PKB. Biochemical Journal 346 561-576.
112. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ & Witerfield MD 2001 Synthesis and function of 3-phosphorylated inositol lipids. Annual Review of Biochemistry 70 535-602.
113. Vecchione C, Patrucco E, Marino G, Barberis L, Poulet R, Aretini A, Maffei A, Gentile MT, Storto M, Azzolino O et al. 2005 Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma. Journal of Experimental Medicine 201 1217-1228.
114. Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F & Dolphin AC 2004 PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nature Neuroscience 7 939-946.
115. Voigt P, Brock C, Nurnberg B & Schaefer M 2005 Assigning functional domains within the p101 regulatory subunit of phosphoinositide 3-kinase gamma. Journal of Biological Chemistry 280 5121-5127.
116. Walker EH, Perisic O, Ried C, Stephens L & Williams RL 1999 Structural insights into phosphoinositide, 3-kinase catalysis and signalling. Nature 402 313-320.
117. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP & Williams RL 2000 Structural determinants of phosphomositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Molecular Cell 6 909-919.
118. Wang Y, Kuropatwinski KK, White DW, Hawley TS, Hawley RG, Tartaglia LA & Baumann H 1997 Leptin receptor action in hepatic cells. Journal of Biological Chemistry 272 16216-16223.
119. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI et al. 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 900-904.
120. Wullschleger S, Loewith R & Hall MN 2006 TOR signaling in growth and metabolism. Cell 124 471-484.
121. Xu Y, Seet LF, Hanson B & Hong W 2001 The Phoxhomology (PX) domain, a new player in phosphoinositide signalling. Biochemical Journal 360 513-530.
122. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA & Backer JM 1998 Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Molecular and Cellular Biology 18 1379-1387
123. Zhao AZ, Shinohara MM, Huang D, Shimizu M, Eldar-Finkelman H, Krebs EG, Beavo JA & Bornfeldt KE 2000 Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. Journal of Biological Chemistry 275 11348-11354.